These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1899849)

  • 21. The anesthetic implications of Crigler-Najjar syndrome.
    Robards C; Brull SJ
    Anesth Analg; 2007 Feb; 104(2):435-6. PubMed ID: 17242105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy outcome in maternal Crigler-Najjar syndrome type II: a case report and systematic review of the literature.
    Passuello V; Puhl AG; Wirth S; Steiner E; Skala C; Koelbl H; Kohlschmidt N
    Fetal Diagn Ther; 2009; 26(3):121-6. PubMed ID: 19752526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Crigler-Najjar syndrome type II in a 17-year-old girl].
    Schwegler U; May B; Müller KM
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():83-4. PubMed ID: 7483726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.
    Kummer O; Hammann F; Haschke M; Krähenbühl S
    Br J Clin Pharmacol; 2016 May; 81(5):1002-4. PubMed ID: 26692114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome.
    Gailite L; Rots D; Pukite I; Cernevska G; Kreile M
    BMC Pediatr; 2018 Oct; 18(1):317. PubMed ID: 30285761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type II crigler-Najjar syndrome with intrahepatic cholestasis.
    Kagita A; Adachi Y; Kambe A; Kamisako T; Yamamoto T
    J Gastroenterol; 1994 Apr; 29(2):214-7. PubMed ID: 8012512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum bilirubin fractions in healthy subjects and patients with unconjugated hyperbilirubinemia.
    Adachi Y; Katoh H; Fuchi I; Yamamoto T
    Clin Biochem; 1990 Jun; 23(3):247-51. PubMed ID: 2372939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings: Prolonged survival in the Crigler-Najjar syndrome: ultrastructural and dietary studies.
    Gollan JL; Huang SN; Billing BH; Sherlock S
    Gut; 1974 Oct; 15(10):838. PubMed ID: 4434967
    [No Abstract]   [Full Text] [Related]  

  • 29. Kernicterus in a child with Crigler-Najjar Syndrome Type II.
    Poddar B; Bharti B; Goraya J; Parmar VR
    Trop Gastroenterol; 2002; 23(1):33-4. PubMed ID: 12170921
    [No Abstract]   [Full Text] [Related]  

  • 30. Unconjugated hyperbilirubinemia. Physiologic evaluation and experimental approaches to therapy.
    Berk PD; Martin JF; Blaschke TF; Scharschmidt BF; Plotz PH
    Ann Intern Med; 1975 Apr; 82(4):552-70. PubMed ID: 1119773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
    Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
    Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of Crigler-Najjar syndrome type I: long survival with bilirubin adsorption and liver transplantation].
    Shimizu N; Mizutani M; Aoki T
    No To Hattatsu; 2005 Jul; 37(4):337-41. PubMed ID: 16026101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral calcium phosphate: a new therapy for Crigler-Najjar disease?
    Van der Veere CN; Jansen PL; Sinaasappel M; Van der Meer R; Van der Sijs H; Rammeloo JA; Goyens P; Van Nieuwkerk CM; Oude Elferink RP
    Gastroenterology; 1997 Feb; 112(2):455-62. PubMed ID: 9024299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Crigler-Najjar syndrome, type I. Therapeutic dilemmas].
    Jesić M; Maglajlić S
    Srp Arh Celok Lek; 2000; 128(11-12):389-92. PubMed ID: 11337919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome.
    Perretti A; Crispino G; Marcantonio L; Lenta S; Caropreso M; Manganelli F; Scianguetta S; Iorio R; Iolascon A; Vajro P
    Neuropediatrics; 2007 Aug; 38(4):173-8. PubMed ID: 18058623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report.
    Shi X; Aronson S; Khan AS; Bosma PJ
    BMC Pediatr; 2019 May; 19(1):173. PubMed ID: 31142299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistant unconjugated hyperbilirubinemia in an infant with crigler-najjar syndrome type I.
    Kulkarni ML; C NR
    Indian Pediatr; 2003 Dec; 40(12):1209-10. PubMed ID: 14722376
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of Crigler-Najjar syndrome of type II].
    Mori Y; Kimura H; Suehiro K; Naritomi Y; Maeda Y; Kusaba T; Ishibashi D
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):102-3. PubMed ID: 1902498
    [No Abstract]   [Full Text] [Related]  

  • 39. [The first case of Crigler-Najjar syndrome in the Czech Republic].
    Vítek L; Bosma P; de Boer A; Jirsa M; Brodanová M; Kotal P
    Cas Lek Cesk; 1996 Feb; 135(4):114-6. PubMed ID: 8625381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Excretion of D-glucaric-acid in newborns with non-hemolytic hyperbilirubinemia after phenobarbital treatment (author's transl)].
    Roth B; Heimann G; Gladtke E
    Padiatr Padol; 1977; 12(4):385-93. PubMed ID: 904946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.